Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 8855179)

Published in Hepatology on October 01, 1996

Authors

A Pauwels1, N Mostefa-Kara, B Debenes, E Degoutte, V G Lévy

Author Affiliations

1: Unite de Soins Intensifs, Service d'Hépato-Gastroentérologie, Hôpital Saint-Antoine, Paris, France.

Articles citing this

UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut (2005) 1.93

Spontaneous bacterial peritonitis. World J Gastroenterol (2009) 1.15

Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol (2014) 1.00

Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol (2011) 0.99

The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions. Surg Endosc (2011) 0.98

Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage. Dig Dis Sci (2008) 0.95

Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci (2001) 0.94

Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study. J Korean Med Sci (2006) 0.94

The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage. PLoS One (2013) 0.87

Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87

Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol (2015) 0.86

Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med Sci (2008) 0.86

Improving survival in decompensated cirrhosis. Int J Hepatol (2012) 0.86

Spontaneous bacterial peritonitis. Postgrad Med J (2007) 0.83

Current Management Strategies for Acute Esophageal Variceal Hemorrhage. Curr Hepatol Rep (2014) 0.83

Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81

Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. World J Gastroenterol (2014) 0.80

General aspects of the treatment of alcoholic hepatitis. World J Hepatol (2011) 0.77

The influential roles of antibiotics prophylaxis in cirrhotic patients with peptic ulcer bleeding after initial endoscopic treatments. PLoS One (2014) 0.76

Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial. J Pharmacol Pharmacother (2015) 0.75

Renal dysfunction in cirrhosis: diagnosis, treatment and prevention. MedGenMed (2004) 0.75

Acute management and secondary prophylaxis of esophageal variceal bleeding: a western Canadian survey. Can J Gastroenterol (2006) 0.75

Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1. Dig Dis Sci (2007) 0.75

Articles by these authors

Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol (1993) 3.24

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology (1988) 1.79

[Drying of cirrhotic ascites by continuous intravenous reinjection of concentrated ascitic fluid]. Ann Med Interne (Paris) (1971) 1.46

[Cerebrovascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients]. Gastroenterol Clin Biol (1987) 1.33

Fatal hepatitis after herbal tea. Lancet (1992) 1.15

Treatment of ascites by reinfusion of concentrated peritoneal fluid--review of 318 procedures in 210 patients. Postgrad Med J (1975) 1.12

Bacterial meningitis in cirrhosis: review of 16 cases. J Hepatol (1997) 0.99

[Primary biliary cirrhosis and pernicious anemia. A fortuitous association? (author's transl)]. Gastroenterol Clin Biol (1980) 0.93

[Meningitis caused by Campylobacter fetus fetus. A case report]. Presse Med (1985) 0.90

[Acute fatal hepatitis during treatment with diclofenac (Voltarène)]. Gastroenterol Clin Biol (1984) 0.87

[Involvement of the peripheral and pyramidal nervous system in Crohn disease. Determining role of folic acid deficiency]. Sem Hop (1983) 0.85

[Effect of aldactone on potassium storage in patients with ascitic cirrhosis]. Ann Med Interne (Paris) (1970) 0.85

Liver ganglioside storage after perhexiline maleate. Lancet (1977) 0.84

The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients). J Hepatol (1986) 0.82

[Hepatic lesions due to perhexiline maleate (author's transl)]. Gastroenterol Clin Biol (1978) 0.82

[Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients]. Gastroenterol Clin Biol (1989) 0.81

[Hepatotoxicity of medicinal plants and plant-based preparations]. Gastroenterol Clin Biol (1993) 0.81

[Chylous ascites in cirrhosis. Retrospective study of 20 cases]. Gastroenterol Clin Biol (1990) 0.81

Hepatoma after thorotrast. Morphological and autoradiographic data. Acta Histochem (1984) 0.80

[Chronic hepatic encephalopathies. Acquired cerebral degeneration not due to Wilson's disease]. Sem Hop (1983) 0.79

[Letter: Side-to-side portacaval anastomosis with interposed venous prosthesis, in 2 cases of chronic Budd-Chiari syndrome]. Nouv Presse Med (1974) 0.78

[Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit]. Gastroenterol Clin Biol (1996) 0.78

[Fatal hepatitis in a female patient treated with ranitidine]. Gastroenterol Clin Biol (1989) 0.78

[Is fluindione hepatotoxic?]. Gastroenterol Clin Biol (1990) 0.77

[Acute pancreatitis in benign viral hepatitis A]. Gastroenterol Clin Biol (1987) 0.77

[Purtscher' ischemic retinopathy consecutive to an acute pancreatitis]. Gastroenterol Clin Biol (2001) 0.77

[Hepatic overload of gangliosides after perhexiline maleate. Morphological and biochemical course (author's transl)]. Nouv Presse Med (1977) 0.77

[Intractable hiccup caused by hiatal hernia with esophagitis]. Presse Med (1989) 0.77

Ischemic hepatitis in cirrhosis: not so rare, not always lethal. J Clin Gastroenterol (1993) 0.76

[Gastric protein loss and alcoholic cirrhosis. Study by measurement of gastric clearance of alpha 1-antitrypsin]. Gastroenterol Clin Biol (1996) 0.75

[Hepatitis caused by ranitidine]. Gastroenterol Clin Biol (1985) 0.75

[A rare etiology of ascitic fluid infection in cirrhosis: Pasteurella multocida]. Gastroenterol Clin Biol (1988) 0.75

[Non-surgical treatment of biliary stenoses after hepatic transplantation]. J Radiol (1997) 0.75

[Endoscopic ligation: a new technic in the treatment of esophageal varices]. Ann Gastroenterol Hepatol (Paris) (1993) 0.75

[Portacaval anastomosis for intractable cirrhotic ascites. A study in 18 patients (author's transl)]. Gastroenterol Clin Biol (1981) 0.75

[Water-electrolyte disorders in liver cirrhosis. Accepted ideas and new ideas]. Ann Med Interne (Paris) (1969) 0.75

[Mesenteric panniculitis after apparently cured hypersplenic cirrhosis. One case]. Nouv Presse Med (1976) 0.75

[Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)]. Nouv Presse Med (1979) 0.75

[Hepatoid adenocarcinoma of the stomach: an unusual anatomo-clinical entity?]. Ann Gastroenterol Hepatol (Paris) (1991) 0.75

[Hepatotoxicity of drugs. 9th update of the bibliographic database of hepatic involvements and related drugs]. Gastroenterol Clin Biol (1996) 0.75

[Medical treatment of biliary lithiasis]. Rev Prat (1982) 0.75

[Disseminated aspergillosis in a woman with liver cirrhosis caused by viral C hepatitis]. Gastroenterol Clin Biol (1993) 0.75

Liver ultrastructure in cholesterolic gallstone patients before and after treatment with chenodeoxycholic acid. Gastroenterol Clin Biol (1980) 0.75

[Ineffectiveness of various potassium salts]. Rev Med Chir Mal Foie (1968) 0.75

[Letter: Bile acids in benign recurrent cholestasis]. Nouv Presse Med (1975) 0.75

[Budd-Chiari syndrome and membranous obstruction of the suprahepatic inferior vena cava. Treatment by percutaneous intraluminal angioplasty]. Gastroenterol Clin Biol (1985) 0.75

[Oxatomide-induced acute cholestatic hepatitis]. Gastroenterol Clin Biol (1992) 0.75

[Contribution to the study of intraphepatic cholestasis: the role of cholangiolitis]. Rev Med Chir Mal Foie (1966) 0.75

[A case of lymphoid myelofibrosis. Anatomo-clinical and critical study]. Sem Hop (1967) 0.75

[Intractable cirrhotic ascites. Reinjection of ascitic fluid. Portacaval anastomosis]. Rev Med Chir Mal Foie (1965) 0.75

[Primary biliary cirrhosis and systemic lupus erythematosus. Association or succession? (author's transl)]. Gastroenterol Clin Biol (1981) 0.75

[Letter: Inversion of the portal blood flow in the Budd-Chiari syndrome: A misleading angiographic sign]. Nouv Presse Med (1975) 0.75

Chenodeoxycholic acid in the prevention of migraine. N Engl J Med (1978) 0.75

[A case of cirrhosis with tubular acidosis]. Ann Med Interne (Paris) (1972) 0.75

[Gallbladder lithiasis and cirrhosis: prevalence and risk factors in 150 patients]. Gastroenterol Clin Biol (1988) 0.75

[Diagnosis of icterus, 1981]. Ann Med Interne (Paris) (1981) 0.75

[Arthropathy caused by fluoroquinolones in a patient after liver transplantation]. Rev Med Interne (1993) 0.75

[Hepatotoxicity of drugs. 8th updated bibliographic database of hepatic lesions and responsible drugs]. Gastroenterol Clin Biol (1995) 0.75

[Hypersplenism in Mediterranean cirrhosis. Is splenectomy useful?]. Tunis Med (1986) 0.75

[Mesenteric-caval anastomosis using an interposed dacron graft. Apropos of 5 cases]. Nouv Presse Med (1975) 0.75

[Cytological criteria of infected ascites in cirrhosis]. Gastroenterol Clin Biol (1982) 0.75

[Acholangic cholestatic hepatitis evolving towards xanthomatosis and cirrhosis]. Ann Med Interne (Paris) (1973) 0.75

[Apropos of biological and histological anomalies of the liver associated with oral contraceptives. Note on the behaviour of biliary salts, BSP and indocyanine green]. Pathol Biol (1968) 0.75

[Hepatotoxicity of drugs. 10th update of the bibliographic database of hepatic involvements and responsible drugs]. Gastroenterol Clin Biol (1997) 0.75

[Klebsiella oxytoca-associated colitis after oral administration of fusidic acid]. Gastroenterol Clin Biol (2000) 0.75

[I. What can one expect from chenic acid excluding lithiasis?]. Med Chir Dig (1979) 0.75

[Peritoneo-venous shunting for intractable ascites. Report of a series of 23 patients treated with the Le Veen valve (author's transl)]. Gastroenterol Clin Biol (1979) 0.75

[Hepatocellular carcinoma and autoimmune chronic active hepatitis]. Gastroenterol Clin Biol (1987) 0.75

[Letter: Peritoneo-venous drainage of cirrhotic ascites. Remarks on 4 cases]. Nouv Presse Med (1976) 0.75

[Fibrolamellar carcinoma of the liver: hepatocellular carcinoma with favourable prognosis]. Gastroenterol Clin Biol (1984) 0.75

[Unusual and unknown complication of ascites: meralgia paresthetica]. Gastroenterol Clin Biol (1990) 0.75

[Anatomo-clinical observation of a case of lymphoid myelofibrosis]. Nouv Rev Fr Hematol (1968) 0.75

[II. Prevention of migraine using chenodeoxycholic acid (C.D.C.A.)]. Med Chir Dig (1979) 0.75

[Consumption coagulopathy after peritoneojugular shunt (30 cases)]. Gastroenterol Clin Biol (1980) 0.75

[Hepatotoxicity of drugs. Update of the data bank on hepatic involvement and the responsible drugs]. Gastroenterol Clin Biol (1989) 0.75

[Ischemic colitis after cocaine abuse]. Gastroenterol Clin Biol (1992) 0.75

[Hepatotoxicity of drugs. Update of a data bank of hepatic involvements and responsible drugs]. Gastroenterol Clin Biol (1988) 0.75

Treatment of intra-heptic cholestasis in primary biliary cirrhosis by long term plasmapheresis. Life Support Syst (1983) 0.75

[Copper metabolism: ultimate therapeutic implications in cholestasis]. Med Chir Dig (1981) 0.75

[Protein losing enteropathy and alcoholic cirrhosis (author's transl)]. Gastroenterol Clin Biol (1982) 0.75

[Propranolol and hemorrhage in cirrhosis]. Gastroenterol Clin Biol (1985) 0.75

[Variations of the accelerin level after splenectomy in cirrhosis]. Rev Med Chir Mal Foie (1968) 0.75

[Hypokalemia, potassium loss and liver cirrhosis. Value of potassium chloride sustained-release tablets]. Therapeutique (1971) 0.75

[Angiomyolipoma of the liver. A fortuitous echographic detection]. Gastroenterol Clin Biol (1985) 0.75